October 01, 2016 5:18 PM ET


Company Overview of Adheron Therapeutics, Inc.

Key Executives for Adheron Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Michael Brenner M.D.No RelationshipsScientific Founder--
David L. Castaldi 14 RelationshipsCo-Founder and Director76
David Lee M.D., Ph.D.No RelationshipsScientific Founder--

Adheron Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David L. Castaldi 14 RelationshipsAdheron Therapeutics, Inc.76
Rajeev Dadoo Ph.D. 74 RelationshipsSR One--
Ron Laufer M.D., M.P.H. 44 RelationshipsMedImmune Ventures, Inc.49
Isai Peimer 3 RelationshipsAdheron Therapeutics, Inc.38
View All Board Members

Adheron Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Adheron Therapeutics, Inc. CEO Compensation
Industry Average


Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET
Gujarat Themis Biosyn Ltd. Announces Board Changes
September 23, 2016 10:41 AM ET
Merck KGaA Appoints Isabel De Paoli as Chief Strategy Officer, Effective 1 October 2016
September 23, 2016 12:00 AM ET
Lannett Company, Inc. Announces Resignation of Mahendra Dedhiya as Chief of Scientific Affairs
September 22, 2016 10:53 AM ET
Sharon Bio-Medicine Ltd Appoints Deepali Bhatia as Company Secretary & Compliance Officer
September 22, 2016 7:15 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adheron Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.